Protective effects of ranolazine on ventricular fibrillation induced by activation of the ATP-dependent potassium channel in the rabbit heart

Journal of Cardiovascular Pharmacology and Therapeutics

Volumn 1, Issue 2, 1996, Pages 141-148

  Gralinski, Michael R ^a   Chi, Liguo ^a   Park, James L ^a   Friedrichs, Gregory S ^a   Tanhehco, Elaine J ^a   McCormack, James G ^b   Lucchesi, Benedict R ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b HERIOT WATT UNIVERSITY   (United Kingdom)

Author keywords

Antiarrhythmic; Antifibrillatory; Arrhythmia; Pyruvate dehydrogenase

Indexed keywords

EID: 0001440335     PISSN: 10742484     EISSN: 19404034     Source Type: Journal    
DOI: 10.1177/107424849600100208     Document Type: Article

References (23)

1. Allely MC, Alps BJ. The effects of the novel antianginal agent ranolazine (i.d.) in a canine model of transient myocardial ischemia. Br J Pharmacol 93:246P, 1988.
2. Allely MC, Alps BJ. Prevention of myocardial enzyme release by ranolazine in a primate model of ischaemia with reperfusion. Br J Pharmacol 99:5, 1990.
3. Cocco G. Rousseau MF, Bouvy T,et al.Effects of a new metabolic modulator, ranolazine, on exercise tolerance in angina pectoris patients treated with beta-blocker or diltiazem. J Cardiovasc Pharmacol 20:131, 1992.
4. Allely MC, Brown CM, Kenny BA, Kilpatrick AT, Martin A, Spedding M. Modulation of al-adrenoreceptors in rat left ventricle by ischemia and acyl carnitine: protection by ranolazine. J Cardiovasc Pharmacol 21:869, 1993.
5. Clarke B, Spedding M, Patmore L, McCormack JG. Protective effects of ranolazine in guinea pig hearts during low-flow ischemia and their association with increases in active pyruvate dehydrogenase. Br J Pharmacol 109:748, 1993.
6. Ferrandon P, Armstrong PM, Pascal JC. Protective effects of the novel anti-ischemic agent ranolazine (RS-43285) in perfused rat hearts. Br J Pharmacol 93(Suppl):247, 1993.
7. Ferrandon P, Fligeiel E, Chaylat C, Armstrong JM. Ranolazine but not allopurinol or dipyridamole reduces the ventricular acidosis and lactate produced by low perfusion flow in isolated rat hearts (abstr). Therapie 45:10, 1991.
8. Gralinski MR, Black SC, Kilgore KS, Chou AY, McCormack JG, Lucchesi BR. Cardioprotective effects of ranolazine (RS-43285) in the isolated perfused rabbit heart. Cardiovasc Res 28:1231, 1991.
9. Chi L, Black SC, Kuo PI, Fagbemi SO, Lucchesi BR. Actions of pinacidil at a reduced potassium concentration: A direct cardiac effect possibly involving the ATP-dependent potassium channel. J Cardiovasc Pharmacol 21:179, 1993.
10. Arena JP, Kass RS. Activation of ATP-sensitive K channels in heart cells by pinacidil: dependence on ATP. Am J Physiol 257:H2092, 1989.
11. Nakayama K, Fan Z, Marumo F, Hiraoka M. Interrelation between pinacidil and intracellular ATP concentrations on activation of the ATP-sensitive K+ current in guinea pig ventricular myocytes. Circ Res 67:1124, 1990.
12. Martin CL, Chinn K. Pinacidil opens ATP-dependent K+ channels in cardiac myocytes in an ATP-and temperature-dependent manner. J Cardiovasc Pharmacol 15:510, 1990.
13. Sanguinetti MC. Modulation of potassium channels by antiarrhythmic and antihypertensive drugs. Hypertension 19:228, 1992.
14. Light PE, Allen BG, Walsh MP, French RJ. Regulation of adenosine triphosphate-sensitive potassium channels from rabbit ventricular myocytes by protein kinase C and type 2A protein phosphatase. Biochemistry 34:7252, 1995.
15. Wollenben CD, Sanguinetti MC, Siegl PK. Influence of ATP-sensitive potassium channel modulators on iscliemiainduced fibrillation in isolated rat hearts. J Mol Cell Cardiol 21:783, 1989.
16. Sanguinetti MC, Schott AL, Zingaro GJ, Siegel PKS. BRL34915 (cromokalim) activates ATP-sensitive K current in cardiac muscle. Proc Natl Acad Sci 85:8360, 1988.
17. Noma A. ATP-regulated K+ channels in cardiac muscle. Nature 305:147, 1983.
18. Vleugels A, Vereecke J, Carmeliet E. Ionic currents during hypoxia in voltage-clamped cat ventricular muscle. Circ Res 305:147, 1980.
19. Gasser RN, Vaughan-Jones RD. Mechanism of potassium efflux and action potential shortening during ischaemia in isolated mammalian cardiac muscle. J Physiol 431:713, 1990.
20. Lodge JP, Lam FT, Perry SL, Giles GR. Ranolazine: A new drug with beneficial effects on renal preservation. Transplantation 50:755, 1990.
21. Kobayashi K, Neely JR. Effects of ischemia and reperfusion on pyruvate dehydrogenase activity in isolated rat hearts. J Mol Cell Cardiol 15:359, 1983.
22. Hutter JF, Piper HM, Spieckerman PG. Effect of fatty acid oxidation on efficiency of energy production in rat heart. Am J Physiol 249:H723, 1985.
23. Burkhoff D, Weiss RG, Schulman SP, Kalil-Filho R, Wannenburg T, Gerstenblith G. Influence of metabolic substrate on rat heart function and metabolism at different coronary flows. Am J Physiol 261:H741, 1991.